APA (7th ed.) Citation

Bongiovanni, A., Liverani, C., Foca, F., Bergamo, F., Leo, S., Pusceddu, S., . . . Ibrahim, T. (2024). A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas. European journal of cancer (1990), 208, 114129. https://doi.org/10.1016/j.ejca.2024.114129

Chicago Style (17th ed.) Citation

Bongiovanni, Alberto, et al. "A Randomized Phase II Trial of Captem or Folfiri as Second-line Therapy in Neuroendocrine Carcinomas." European Journal of Cancer (1990) 208 (2024): 114129. https://doi.org/10.1016/j.ejca.2024.114129.

MLA (9th ed.) Citation

Bongiovanni, Alberto, et al. "A Randomized Phase II Trial of Captem or Folfiri as Second-line Therapy in Neuroendocrine Carcinomas." European Journal of Cancer (1990), vol. 208, 2024, p. 114129, https://doi.org/10.1016/j.ejca.2024.114129.